Michael A Partridge

7PUBLICATIONS
37CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 10, 2026
Immunogenicity in Approved Adeno-Associated Virus-Based Gene Therapies: A Framework for a Tailored Assessment Strategy.

|May 19, 2026
Immunogenicity Assessment for siRNA Therapeutics: A Risk-Based Proposal for Event-Driven Testing.

|Jan 06, 2026
Assessment of Immune Responses Against AAV Encoded Transgene Products.

Boris Gorovits, Mitra Azadeh, Michele Fiscella

|Aug 13, 2025
Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays.

Michael A Partridge, Lynn Kamen, Bonnie Wu

|Mar 15, 2025
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.

Sophie Shubow, Michele Gunsior, Amy Rosenberg

|Aug 25, 2016
Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.

Michael A Partridge, Shobha Purushothama, Chinnasamy Elango

Pageof 2

Frequent Collaborators

3 joint publications

Yanmei Lu

2 joint publications

Shobha Purushothama

2 joint publications

Bonnie Wu

2 joint publications

An Zhao